págs. 249-258
Brentuximab vedotin: its role in the treatment of anaplastic large cell and Hodgkin's lymphoma.
págs. 259-270
Crizotinib for the treatment of patients with advanced non-small cell lung cancer.
Daniel W. Bowles, Andrew James Weickhardt, Robert C. Doebele, D. Ross Camidge, Antonio Jimeno
págs. 271-282
págs. 283-292
New thrombopoietin receptor agonists for platelet disorders.
S. Homeida, Caroline Ebdon, Paul Batty, B. Jackson, S. Kolade, C. Bateman, Yingying Peng, Roberto Stasi
págs. 293-301
© 2001-2024 Fundación Dialnet · Todos los derechos reservados